Publications by MSCCC Members

Collapse All | Expand All

• Cohen JA, Imrey PB, Calabresi PA, Edwards KR, Eickenhorst T, Felton WL, 3rd, Fisher E, Fox RJ, Goodman AD, Hara-Cleaver C, Hutton GJ, Mandell BF, Scott TF, Zhang H, Apperson-Hansen C, Beck GJ, Houghtaling PL, Karafa MT, Stadtler M. Results of the Avonex Combination Trial (ACT) in relapsing-remitting MS. Neurology. 2009;72:535-541.
• Hutton GJ, Avila M, Suarez GA. Pneumocephalus after an epidural steroid injection. Clin Neurol Neurosurg. 2009;111:309-10.
• Rivera VM. Multiple Sclerosis in Latin America. Reality and Challenge. Neuroepidemiology. 2009;32:294-295.

Collapse All | Expand All

• Brodsky M, Orengo-Nania S, Hutton GJ, Slight B, Buckley EG, Massey EW, Anderson MM, Duncan LB, Bhatti MT, Greer M, Burke R, Preston R, Goodwin J, Cross A, Garcia-Ovando Y, Wall M, Musser C, Carney B, Longmuir R, Randhawa S, et al. Visual function 15 years after optic neuritis: a final follow-up report from the Optic Neuritis Treatment Trial. Ophthalmology. 2008;115:1079-1082 e5.
• Cohen JA, Calabresi PA, Chakraborty S, Edwards KR, Eickenhorst T, Felton WL, 3rd, Fisher E, Fox RJ, Goodman AD, Hara-Cleaver C, Hutton GJ, Imrey PB, Ivancic DM, Mandell BF, Perryman JE, Scott TF, Skaramagas TT, Zhang H. Avonex Combination Trial in relapsing--remitting MS: rationale, design and baseline data. Mult Scler. 2008;14:370-82.
• Coles AJ, Compston DA, Selmaj KW, Lake SL, Moran S, Margolin DH, Norris K, Tandon PK. Alemtuzumab vs. interferon beta-1a in early multiple sclerosis. N Engl J Med. 2008;359:1786-801.
• Lotze TE, Northrop JL, Hutton GJ, Ross B, Schiffman JS, Hunter JV. Spectrum of pediatric neuromyelitis optica. Pediatrics. 2008;122:e1039-47.
• Nash RA, Stuve O, Bowen JD, Frohman EM, Griffith LM, Hutton GJ, Kraft GH, Popat U, Racke MK, Muraro PA. Autologous HSCT for advanced MS: is the glass half-empty or really half-full? Brain. 2008;131:e89; author reply e90.
• Suarez Zambrano GA, Hutton GJ. Heart-shaped lesion secondary to neurosarcoidosis. Arch Neurol. 2008;65:1388-9.

Collapse All | Expand All

• Ordonez L, Skromne E, Ontaneda D, Rivera VM. Multiphasic disseminated encephalomyelitis, systemic lupus erythematosus and antiphospholipid syndrome. Clin Neurol Neurosurg. 2007;109:102-5.
• Rivera-Olmos VM, Avila MC. [Multiple sclerosis in Latin America. Are McDonald's criteria really applicable?]. Rev Mex Neuroci. 2007;8:49-56.
• Vu T, Carrum G, Hutton G, Heslop HE, Brenner MK, Kamble R. Human herpesvirus-6 encephalitis following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2007;39:705-9.

Collapse All | Expand All

• Skromne E, Rivera VM, Ontaneda D, Ordonez L. Progression of progressive multifocal leukoencephalopathy despite treatment with beta-interferon. Neurology. 2006;66:1787-8; author reply 1787-8.

Collapse All | Expand All

• Rivera VM. Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis. Neurology. 2005;64:2163.
• Rivera VM. Modafinil for the treatment of diminished responsiveness in a patient recovering from brain surgery. Brain Inj. 2005;19:725-7.
• Rivera VM. The terms Latino and Anglo and tendency to early Alzheimer disease. Arch Neurol. 2005;62:1787; author reply 1787-8.
• Zhang J, Hutton G. Role of magnetic resonance imaging and immunotherapy in treating multiple sclerosis. Annu Rev Med. 2005;56:273-302.

Collapse All | Expand All

• Bakshi R, Hutton GJ, Miller JR, Radue EW. The use of magnetic resonance imaging in the diagnosis and long-term management of multiple sclerosis. Neurology. 2004;63:S3-11.
• Hong J, Zang YC, Hutton G, Rivera VM, Zhang JZ. Gene expression profiling of relevant biomarkers for treatment evaluation in multiple sclerosis. J Neuroimmunol. 2004;152:126-39.
• Hong J, Zang YC, Li S, Rivera VM, Zhang JZ. Ex vivo detection of myelin basic protein-reactive T cells in multiple sclerosis and controls using specific TCR oligonucleotide probes. Eur J Immunol. 2004;34:870-81.
• Rivera VM. Esclerosis Multiple: Evidencias, genericos y similares. Rev Mex Neuroci. 2004;5:286-7.
• Rivera-Olmos VM, Hutton GJ, Breitbach WT. Discrepancia entre clínica e imagen: esclerosis múltiple en fase intermedia. Presentación de un caso y revisión del tema [Discrepancy between clinics and image techniques: intermediate phase of multiple sclerosis. A case report and review of the literature]. Rev Mex Neuroci. 2004;5:158-62.
• Sun W, Popat U, Hutton G, Zang YC, Krance R, Carrum G, Land GA, Heslop H, Brenner M, Zhang JZ. Characteristics of T-cell receptor repertoire and myelin-reactive T cells reconstituted from autologous haematopoietic stem-cell grafts in multiple sclerosis. Brain. 2004;127:996-1008.
• Zang YC, Li S, Rivera VM, Hong J, Robinson RR, Breitbach WT, Killian J, Zhang JZ. Increased CD8+ cytotoxic T cell responses to myelin basic protein in multiple sclerosis. J Immunol. 2004;172:5120-7.
• Zang YC, Skinner SM, Robinson RR, Li S, Rivera VM, Hutton GJ, Zhang JZ. Regulation of differentiation and functional properties of monocytes and monocyte-derived dendritic cells by interferon beta in multiple sclerosis. Mult Scler. 2004;10:499-506.

Collapse All | Expand All

• Frohman EM, Goodin DS, Calabresi PA, Corboy JR, Coyle PK, Filippi M, Frank JA, Galetta SL, Grossman RI, Hawker K, Kachuck NJ, Levin MC, Phillips JT, Racke MK, Rivera VM, Stuart WH. The utility of MRI in suspected MS: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2003;61:602-11.
• Frohman TC, Frohman EM, O'Suilleabhain P, Salter A, Dewey RB, Jr., Hogan N, Galetta S, Lee AG, Straumann D, Noseworthy J, Zee D, Corbett J, Corboy J, Rivera VM, Kramer PD. Accuracy of clinical detection of INO in MS: corroboration with quantitative infrared oculography. Neurology. 2003;61:848-50.
• Rivera VM. [Deciding on treatment in multiple sclerosis]. Rev Neurol. 2003;36:80-5.
• Tejada-Simon MV, Zang YC, Hong J, Rivera VM, Zhang JZ. Cross-reactivity with myelin basic protein and human herpesvirus-6 in multiple sclerosis. Ann Neurol. 2003;53:189-97.
• Zang Y, Hong J, Robinson R, Li S, Rivera VM, Zhang JZ. Immune regulatory properties and interactions of copolymer-I and beta-interferon 1a in multiple sclerosis. J Neuroimmunol. 2003;137:144-53.
• Zang YC, Hong J, Rivera VM, Killian J, Zhang JZ. Human anti-idiotypic T cells induced by TCR peptides corresponding to a common CDR3 sequence motif in myelin basic protein-reactive T cells. Int Immunol. 2003;15:1073-80.

Collapse All | Expand All

• Hong J, Tejada-Simon MV, Rivera VM, Zang YC, Zhang JZ. Anti-viral properties of interferon beta treatment in patients with multiple sclerosis. Mult Scler. 2002;8:237-42.
• Rivera VM. II Congreso de LACTRIMS. Rev Neurol. 2002;35:1175-6.
• Tejada-Simon MV, Hong J, Rivera VM, Zhang JZ. Skewed autoantibody reactivity to the extracellular domain of myelin oligodendrocyte glycoprotein in multiple sclerosis. Immunology. 2002;107:403-10.
• Tejada-Simon MV, Zang YC, Hong J, Rivera VM, Killian JM, Zhang JZ. Detection of viral DNA and immune responses to the human herpesvirus 6 101-kilodalton virion protein in patients with multiple sclerosis and in controls. J Virol. 2002;76:6147-54.
• Zang YC, Halder JB, Hong J, Rivera VM, Zhang JZ. Regulatory effects of estriol on T cell migration and cytokine profile: inhibition of transcription factor NF-kappa B. J Neuroimmunol. 2002;124:106-14.
• Zhang J, Hutton G, Zang Y. A comparison of the mechanisms of action of interferon beta and glatiramer acetate in the treatment of multiple sclerosis. Clin Ther. 2002;24:1998-2021.
• Zhang JZ, Rivera VM, Tejada-Simon MV, Yang D, Hong J, Li S, Haykal H, Killian J, Zang YC. T cell vaccination in multiple sclerosis: results of a preliminary study. J Neurol. 2002;249:212-8.

Collapse All | Expand All

• Ciancio SJ, Mutchnik SE, Rivera VM, Boone TB. Urodynamic pattern changes in multiple sclerosis. Urology. 2001;57:239-45.
• Rivera VM, Cabrera JA. Aboriginals with multiple sclerosis: HLA types and predominance of neuromyelitis optica. Neurology. 2001;57:937-8.
• Rivera VM. [Neuroimaging in multiple sclerosis]. Rev Neurol. 2001;32:283-5.
• Rivera VM. [Pharmacologic treatment of multiple sclerosis]. Rev Neurol. 2001;32:285-8.
• Rivera VM. La Decada del Cerebro. Neurociencia. 2001;2:131.
• Tejada-Simon MV, Hong J, Rivera VM, Zhang JZ. Reactivity pattern and cytokine profile of T cells primed by myelin peptides in multiple sclerosis and healthy individuals. Eur J Immunol. 2001;31:907-17.
• Zang YC, Halder JB, Samanta AK, Hong J, Rivera VM, Zhang JZ. Regulation of chemokine receptor CCR5 and production of RANTES and MIP-1alpha by interferon-beta. J Neuroimmunol. 2001;112:174-80.
• Hong J, Zang YC, Tejada-Simon MV, Li S, Rivera VM, Killian J, Zhang JZ. Reactivity and regulatory properties of human anti-idiotypic antibodies induced by T cell vaccination. J Immunol. 2000;165:6858-64.
• Rivera VM, Cabrera JA. La Esclerosis Multiple en Latino America. MEDICO Interamericano. 2000;19:458-65.
• Rivera VM. [The treatment of multiple sclerosis with beta-interferon 1a]. Rev Neurol. 2000;31:470-1.
• Rivera VM. Grupo de Estudio de EM (Mexico): Uso de Agentes Modificadores de la Enfermedad. Neurociencia. 2000;3:29-30.
• Rivera VM. Introduccion al Simposio Latino Americano. Rev Neurol. 2000;31:469.
• Tejada-Simon MV, Zang YC, Yang D, Hong J, Li S, Singh RA, Van den Berg-Loonen E, Killian JM, Rivera VM, Zhang JZ. Aberrant T cell responses to myelin antigens during clinical exacerbation in patients with multiple sclerosis. Int Immunol. 2000;12:1641-50.
• Zang YC, Hong J, Rivera VM, Killian J, Zhang JZ. Preferential recognition of TCR hypervariable regions by human anti-idiotypic T cells induced by T cell vaccination. J Immunol. 2000;164:4011-7.
• Zang YC, Hong J, Tejada-Simon MV, Li S, Rivera VM, Killian JM, Zhang JZ. Th2 immune regulation induced by T cell vaccination in patients with multiple sclerosis. Eur J Immunol. 2000;30:908-13.
• Zang YC, Samanta AK, Halder JB, Hong J, Tejada-Simon MV, Rivera VM, Zhang JZ. Aberrant T cell migration toward RANTES and MIP-1 alpha in patients with multiple sclerosis. Overexpression of chemokine receptor CCR5. Brain. 2000;123 ( Pt 9):1874-82.
• Zang YC, Yang D, Hong J, Tejada-Simon MV, Rivera VM, Zhang JZ. Immunoregulation and blocking antibodies induced by interferon beta treatment in MS. Neurology. 2000;55:397-404.
• Hong J, Zang YC, Tejada-Simon MV, Kozovska M, Li S, Singh RA, Yang D, Rivera VM, Killian JK, Zhang JZ. A common TCR V-D-J sequence in V beta 13.1 T cells recognizing an immunodominant peptide of myelin basic protein in multiple sclerosis. J Immunol. 1999;163:3530-8.
• Kil K, Zang YC, Yang D, Markowski J, Fuoco GS, Vendetti GC, Rivera VM, Zhang JZ. T cell responses to myelin basic protein in patients with spinal cord injury and multiple sclerosis. J Neuroimmunol. 1999;98:201-7.
• Kozovska ME, Hong J, Zang YC, Li S, Rivera VM, Killian JM, Zhang JZ. Interferon beta induces T-helper 2 immune deviation in MS. Neurology. 1999;53:1692-7.
• Singh RA, Zang YC, Shrivastava A, Hong J, Wang GT, Li S, Tejada-Simon MV, Kozovska M, Rivera VM, Zhang JZ. Th1 and Th2 deviation of myelin-autoreactive T cells by altered peptide ligands is associated with reciprocal regulation of Lck, Fyn, and ZAP-70. J Immunol. 1999;163:6393-402.
• Zang YC, Kozovska MM, Hong J, Li S, Mann S, Killian JM, Rivera VM, Zhang JZ. Impaired apoptotic deletion of myelin basic protein-reactive T cells in patients with multiple sclerosis. Eur J Immunol. 1999;29:1692-700.
• Kozovska M, Zang YC, Aebischer I, Lnu S, Rivera VM, Crowe PD, Boehme SA, Zhang JZ. T cell recognition motifs of an immunodominant peptide of myelin basic protein in patients with multiple sclerosis: structural requirements and clinical implications. Eur J Immunol. 1998;28:1894-901.
• Zang YC, Kozovska M, Aebischer I, Li S, Boehme S, Crowe P, Rivera VM, Zhang JZ. Restricted TCR Valpha gene rearrangements in T cells recognizing an immunodominant peptide of myelin basic protein in DR2 patients with multiple sclerosis. Int Immunol. 1998;10:991-8.
• Jerger J, Alford B, Lew H, Rivera V, Chmiel R. Dichotic listening, event-related potentials, and interhemispheric transfer in the elderly. Ear Hear. 1995;16:482-98.
• Trujillo JR, Garcia-Ramos G, Novak IS, Rivera VM, Huerta E, Essex M. Neurologic manifestations of AIDS: a comparative study of two populations from Mexico and the United States. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;8:23-9.
• Safi HJ, Bartoli S, Hess KR, Shenaq SS, Viets JR, Butt GR, Sheinbaum R, Doerr HK, Maulsby R, Rivera VM. Neurologic deficit in patients at high risk with thoracoabdominal aortic aneurysms: the role of cerebral spinal fluid drainage and distal aortic perfusion. J Vasc Surg. 1994;20:434-44; discussion 442-3.
• Crawford ES, Svensson LG, Hess KR, Shenaq SS, Coselli JS, Safi HJ, Mohindra PK, Rivera V. A prospective randomized study of cerebrospinal fluid drainage to prevent paraplegia after high-risk surgery on the thoracoabdominal aorta. J Vasc Surg. 1991;13:36-45; discussion 45-6.
• Mawad ME, Rivera V, Crawford S, Ramirez A, Breitbach W. Spinal cord ischemia after resection of thoracoabdominal aortic aneurysms: MR findings in 24 patients. AJR Am J Roentgenol. 1990;155:1303-7.
• Rivera VM. Safety of intrathecal steroids in multiple sclerosis. Arch Neurol. 1989;46:718-9.
• Jerger JF, Oliver TA, Chmiel RA, Rivera VM. Patterns of auditory abnormality in multiple sclerosis. Audiology. 1986;25:193-209.
• Rivera VM. Multiple sclerosis. Is the mystery beginning to unfold? Postgrad Med. 1986;79:217-32.
• Hannley M, Jerger JF, Rivera VM. Relationships among auditory brain stem responses, masking level differences and the acoustic reflex in multiple sclerosis. Audiology. 1983;22:20-33.
• Rivera VM. Intraspinal steroid therapy. Neurology. 1981;31:1060-1.
• Breitbach W. Nursing care of the patient with cerebrovascular disease. J Pract Nurs. 1980;30:32-3.
• Rivera VM, Grabois M, Deaton W, Breitbach W, Hines M. Modified snake venom in amyotrophic lateral sclerosis. Lack of clinical effectiveness. Arch Neurol. 1980;37:201-3.
• Jankovic J, Rivera VM. Hereditary myoclonus and progressive distal muscular atrophy. Ann Neurol. 1979;6:227-31.
• Jankovic J, Rivera V. Hereditary myoclonus and progressive muscular atrophy: a new syndrome. Trans Am Neurol Assoc. 1978;103:116-8.
• Perez FI, Hruska NA, Stell RL, Rivera VM. Computerized assessment of memory performance in dementia. Can J Neurol Sci. 1978;5:307-12.
• Rivera VM, Patten BM. Neuromyopathy in malignant hyperthermia. J Clin Psychiatry. 1978;39:67-71.
• Rivera VM. Acute hypokalemic myopathy in alcoholism. Arch Neurol. 1978;35:619.
• Guido EM, Rivera VM. Precordialgia as a manifestation of vertebrobasilar insufficiency. J Am Geriatr Soc. 1977;25:463-5.
• Rivera VM. Viruses and multiple sclerosis. Jama. 1977;238:1247.
• Rodriguez J, Rivera VM. Risk factors in stroke in a Mexican-American population (Houston). Neurol Neurocir Psiquiatr. 1977;18:225-34.
• Perez FI, Gay JR, Taylor RL, Rivera VM. Patterns of memory performance in the neurologically impaired aged. Can J Neurol Sci. 1975;2:347-55.
• Perez FI, Rivera VM, Meyer JS, Gay JR, Taylor RL, Mathew NT. Analysis of intellectual and cognitive performance in patients with multi-infarct dementia, vertebrobasilar insufficiency with dementia, and Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1975;38:533-40.
• Rivera VM, Breitbach WB, Swanke L. Letter: Dantrolene in amyotrophic lateral sclerosis. Jama. 1975;233:863-4.
• Rivera VM, Keichian AH, Oliver RE. Persistent parkinsonism following neuroleptanalgesia. Anesthesiology. 1975;42:635-7.